Business Context and Reporting Period
This Form 6-K filing by Sanofi-Aventis (formerly Sanofi-Synthelabo) covers the period ending October 21, 2004. The filing serves to distribute a press release and presentation materials regarding the company's sales figures for the third quarter of 2004.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached exhibits (Exhibit 99.1 Press Release and Exhibit 99.2 Presentation) which are incorporated by reference but not detailed in the cover document text.
Material Changes
The filing text does not explicitly state material changes versus the prior comparable period. It only indicates that sales figures for the third quarter of 2004 were announced in the attached press release.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the cover text of this Form 6-K. Such information is expected to be found in the attached third-quarter sales conference call presentation (Exhibit 99.2).
Investor Verification Checklist
- Verify the specific third-quarter 2004 sales figures in the attached Press Release (Exhibit 99.1).
- Review the third-quarter sales conference call presentation (Exhibit 99.2) for management commentary and operational details.
- Confirm the company's full name change from Sanofi-Synthelabo to Sanofi-Aventis as noted in the filing.
- Check subsequent filings for the full financial statements corresponding to the Q3 2004 period.